Argos Therapeutics has turned to Adaptive Biotechnologies for help with understanding the immune responses triggered by its pipeline of immunotherapies.
Takeda has signed up to work with M2Gen on the ORIEN Avatar research program, giving it Takeda access to deidentified clinical and molecular data.
Andreessen Horowitz’s recently founded $200 million biotech fund has led an investment in software-enabled liquid biopsy upstart Freenome.
Omicia has raised $23 million from Roche’s venture fund and other investors to expand its NGS interpretation and reporting capabilities into new sectors.
George Church and more than 20 other scientists have formally unveiled their controversial project to synthesize the human genome.
Strata Oncology has raised $12 million and teamed up with Thermo Fisher to embark on a campaign to sequence the tumors of 100,000 cancer patients for free.
Twist Bioscience has paired its DNA synthesis capabilities to Desktop Genetics' synthetic guide RNA CRISPR design software,
NantHealth, Dr. Patrick Soon-Shiong’s precision medicine play, has raised $91 million in an IPO that relied heavily on existing investors including Celgene.
The White House has released a security framework to help organizations participating in the Precision Medicine Initiative protect information on individuals.
Amgen and deCode have discovered a genetic variation associated with a 34% reduction in the risk of coronary artery disease in a trove of genome data.